Home > Pressrelease > Healthcare 3D Printing Market worth over $7.1bn by 2027

Healthcare 3D Printing Market worth over $7.1bn by 2027

  • Published Date: June 22, 2021

Healthcare 3D Printing Market size is set to surpass USD 7.1 billion by 2027, according to a new research report by Global Market Insights Inc.

The healthcare 3D printing market growth is attributed to an increasing demand for customized 3D printed devices as well as implants. Further, technological advancement has also enabled 3D printers to mimic patient’s bone structure, simplifying the re-construction of patient’s joints, among others. These factors have been observed to set pace in the market, thereby driving the demand in the short-term forecast period.

Technological advancement significantly influences the healthcare 3D printing market

An increasing number of road accidents across regions is one of the primary concerns of the medical industry. Several end-users are observed to prefer healthcare 3D printed surgical implants over other manufacturing techniques involved. Healthcare 3D printing is increasingly gaining popularity among the surgical community owing to its versatility. As the approach is capable of producing prosthetic limbs as well as dental, hip and spinal implants within a day, these are highly beneficial for critical patient requirements. The ability to produce custom implants and prostheses quickly solve clear and insistent problem in orthopedics, where ordinary implants are insufficient for some patients, mostly in complicated cases. This increases the demand for healthcare 3D printing. Further, it is also noted that nearly 98% of hearing aids manufactured today are personalized with 3D printing according to the patient. This has paved the way for 3D printing in manufacturing certain medical devices, minimizing regulatory hurdles.

High initial costs limit the scale of adoption

The high cost associated with 3D printing restrain its execution into everyday practice. It is found that high resolution 3D printers cost between US$ 40,000 to over US$ 1 million. The high upfront costs have limited the adoption of 3D printers on a larger scale. Additionally, resource costs such as skilled labor to operate the printers and laboratory requirements also increase the overall cost of a 3D printer. Hence, to nullify the same, several end-users prefer outsourcing their 3D printing requirements. However, since the batch size for individual orders is usually smaller, the costs associated with individual products are higher, limiting the industry growth.

Organ generation will largely fuel the segment growth

The magnetic levitation segment in the healthcare 3D printing market is projected to witness 23.5% growth rate through 2027 led by its advantages such as using nanoparticles for bioprinting organs. It is studied to be an easy to reconstruct natural tissue environment in vitro using this magnetic levitation. Moreover, 3D culture formed using magnetic levitation without any special media can be cultured for long time.

Browse key industry insights spread across 120 pages with 231 market data tables & 16 figures & charts from the report,Healthcare 3D Printing Market Size By Product (Syringe based, Magnetic Levitation, Laser Based, Inkjet Based), By Technology (Fused Deposition Modelling (FDM), Selective Laser Sintering (SLS), Stereolithography), By Application (Biosensors, Medical {Pharmaceuticals, Prosthetics and Implants, Tissue and Organ Generation}, Dental), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027in detail along with the table of contents:

Technical advantage is expected to remain the driving factor for selective laser sintering (SLS) technology

The SLS segment captured 28.6% of the market share in 2020. One of the main benefits with this technology is that it does not require support structures whereas, in case of other additive manufacturing technologies require design in such a way that prevents collapse during the production. It is also noted to be a time-efficient technology compared to its other counterparts.

Biosensors increasingly contribute to the healthcare 3D printing market progression

The biosensors segment is poised to reach USD 1.5 billion by 2027. Biosensors have widespread applications over different research and development that has provided the segment with lucrative industry expansion opportunities. For instance, biosensors are used to detect genotoxic compounds by usage of 3D printed microbioreactors. These biosensors integrated with advanced technology are widely used in various fields augmenting the market value of healthcare 3D printing.

Higher rate of acceptance and several suppliers targeting the region make Europe one of the fastest growing regions

Europe healthcare 3D printing market size will account for over USD 2.2 billion by 2027 due to the increasing acceptance of 3D printed devices and implants. Additionally, rising demand for prosthetics as well as surgical implants is also growing the overall demand for healthcare 3D printing in the region.

A mix of organic and inorganic growth strategies shape the supply-side market

Some of the key participants operating in the market include 3D systems, Stratasys, Materialise NV and Renishaw, among others. The market players are noted to focus on strengthening their industry presence across regions and hence engage in strategies such as acquisitions and mergers, among others.

Authors: Sumant Ugalmugle, Rupali Swain